ASX News Health Care Artrya pops +11% on yet another FDA approval for an Aussie biotech Artrya (ASX:AYA) is the latest Aussie biotech stock to see an FDA approval and consequent rewarding… 2 mins28 March 2025 11:50 (AEDT)